TY - JOUR
T1 - Hyperferritinaemia following intrauterine transfusions for Rh isoimmunisation
AU - Anne, Rajendra Prasad
AU - Sundaram, Venkataseshan
AU - Dutta, Sourabh
AU - Kumar, Praveen
N1 - Publisher Copyright:
© BMJ Publishing Group Limited 2019.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Intrauterine transfusion is one of the mainstays of treatment in isoimmunised pregnancies guided by the changes in middle cerebral artery Doppler of the fetus. The common postnatal complications associated with Rh isoimmunisation are high unconjugated bilirubin requiring blood exchange transfusions, cholestasis due to bile inspissation, thrombocytopenia and anaemia. Hyperferritinaemia is an uncommon adverse effect observed in Rh isoimmunised pregnancies. In this case report, we describe the clinical course of a Rh isoimmunised neonate with hyperferritinaemia and transfusion acquired cytomegalovirus disease which resolved. Iron chelation therapy was not necessary.
AB - Intrauterine transfusion is one of the mainstays of treatment in isoimmunised pregnancies guided by the changes in middle cerebral artery Doppler of the fetus. The common postnatal complications associated with Rh isoimmunisation are high unconjugated bilirubin requiring blood exchange transfusions, cholestasis due to bile inspissation, thrombocytopenia and anaemia. Hyperferritinaemia is an uncommon adverse effect observed in Rh isoimmunised pregnancies. In this case report, we describe the clinical course of a Rh isoimmunised neonate with hyperferritinaemia and transfusion acquired cytomegalovirus disease which resolved. Iron chelation therapy was not necessary.
UR - https://www.scopus.com/pages/publications/85061862502
UR - https://www.scopus.com/pages/publications/85061862502#tab=citedBy
U2 - 10.1136/bcr-2018-227225
DO - 10.1136/bcr-2018-227225
M3 - Article
C2 - 30782626
AN - SCOPUS:85061862502
SN - 1757-790X
VL - 12
JO - BMJ Case Reports
JF - BMJ Case Reports
IS - 2
M1 - e227225
ER -